Cargando…

A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study

BACKGROUND: Stigma is a barrier to the uptake of buprenorphine to treat opioid use disorder. Harm reduction treatment models intend to minimize this stigma by organizing care around non-judgmental interactions with people who use drugs. There are few examples of implementing buprenorphine treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kapadia, Shashi N., Griffin, Judith L., Waldman, Justine, Ziebarth, Nicolas R., Schackman, Bruce R., Behrends, Czarina N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815286/ https://www.ncbi.nlm.nih.gov/pubmed/33469774 http://dx.doi.org/10.1007/s11606-020-06409-6

Ejemplares similares

Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020()
por: Behrends, Czarina N., et al.
Publicado: (2022)

The effects of COVID-19 on New York State’s Drug User Health Hubs and syringe service programs: a qualitative study
por: Ude, Mercy, et al.
Publicado: (2023)

Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives
por: Austin, Elizabeth J., et al.
Publicado: (2022)

Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021
por: Des Jarlais, Don C., et al.
Publicado: (2022)

Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings: Harm Reduction in Outpatient Addiction Treatment
por: Taylor, Jessica L., et al.
Publicado: (2021)

Responding to a surge in overdose deaths: perspectives from US syringe services programs
por: Frost, Madeline C., et al.
Publicado: (2022)

Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine
por: Corcorran, Maria A., et al.
Publicado: (2023)

Geriatric Opioid Harm Reduction: Interprofessional Student Learning Outcomes
por: Zanjani, Faika, et al.
Publicado: (2020)

Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies
por: Hawk, Kathryn F., et al.
Publicado: (2015)

Opioid Use Stigma: An Examination of Student Attitudes on Harm Reduction Strategies
por: Reynolds, Gemma, et al.
Publicado: (2022)

Editorial: Opioid overdose and harm reduction approaches to combat the looming crisis
por: Gunturu, Sasidhar, et al.
Publicado: (2023)

Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder
por: Tabatabaeepour, Nadia, et al.
Publicado: (2022)

How an emergency department is organized to provide opioid-specific harm reduction and facilitators and barriers to harm reduction implementation: a systems perspective
por: Jiao, Sunny, et al.
Publicado: (2023)

A scoping review of opioid harm reduction interventions for equity-deserving populations
por: Milaney, Katrina, et al.
Publicado: (2022)

Opioid harm reduction and stigma: proposed methods to improve the perception of people with addiction
por: López-Ramírez, Enrique, et al.
Publicado: (2023)

Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial
por: Kapadia, Shashi N, et al.
Publicado: (2022)

Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse
por: Stancil, Stephani L., et al.
Publicado: (2021)

Health care and harm reduction provider perspectives on treating older adults who use non-medical opioids: a qualitative study set in Chicago
por: Mason, Maryann, et al.
Publicado: (2023)

2216. Hepatitis C Treatment Wanted Yet Not Received: Barriers to Receiving HCV Treatment Among People Who Inject Drugs
por: Kapadia, Shashi, et al.
Publicado: (2018)

Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island
por: Zang, Xiao, et al.
Publicado: (2022)

Understanding Polarizing Community Perspectives on Harm Reduction Strategies: Challenges to Addressing the Opioid Crisis in Appalachian Pennsylvania
por: Creasy, Stephanie L., et al.
Publicado: (2021)

Drug use, homelessness and health: responding to the opioid overdose crisis with housing and harm reduction services
por: Milaney, Katrina, et al.
Publicado: (2021)

Examining Attitudes and Beliefs that Inhibit Pharmacist Implementation of a Statewide Opioid Harm Reduction Program
por: Frenzel, Oliver C., et al.
Publicado: (2020)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
por: Scheidell, Joy D, et al.
Publicado: (2022)

Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19
por: Seaman, Andrew, et al.
Publicado: (2021)

Harm reduction social work with people who use drugs: a qualitative interview study with social workers in harm reduction services in Sweden
por: Richert, Torkel, et al.
Publicado: (2023)

Mapping Community Opioid Exposure Through Wastewater-Based Epidemiology as a Means to Engage Pharmacies in Harm Reduction Efforts
por: Duvallet, Claire, et al.
Publicado: (2020)

Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence
por: Rouhani, Saba, et al.
Publicado: (2019)

Pilot survey of prescription opioid use patterns and engagement with harm-reduction strategies in emergency department patients
por: Fox, Lindsay M., et al.
Publicado: (2021)

Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community
por: Heo, Moonseong, et al.
Publicado: (2023)

Harm Reduction Journal
por: Drucker, Ernest
Publicado: (2004)

The Olympics and harm reduction?
por: Kayser, Bengt, et al.
Publicado: (2012)

Harm reduction in hospitals
por: Sharma, Malika, et al.
Publicado: (2017)

Decolonizing harm reduction
por: Lasco, Gideon
Publicado: (2022)

Assessing pharmacy student experience with, knowledge of and attitudes towards harm reduction: illuminating barriers to pharmacist-led harm reduction
por: Mahon, Lily Rowan, et al.
Publicado: (2018)

A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction
por: Meyer, Jaimie P., et al.
Publicado: (2020)

Harm Reduction Principles in a Street Medicine Program: A Qualitative Study
por: Frankeberger, Jessica, et al.
Publicado: (2022)

Harms of prescription opioid use in the United States
por: Imtiaz, Sameer, et al.
Publicado: (2014)

Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
por: Jakubowski, Andrea, et al.
Publicado: (2022)

State laws and policies to reduce opioid-related harm: A qualitative assessment of PDMPs and naloxone programs in ten U.S. States
por: Whitmore, Christine C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ns76ad9hj3tlu47lug8hiauiv1